Stay updated on Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF

Sign up to get notified when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.
Latest website image capture
Clouds background image

Latest updates to the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to the comparison of safety, efficacy, and tolerability of different drug regimens for HIV treatment in adult participants.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:37.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. This change clarifies the criteria used to determine eligibility for the study.
    Difference
    33%
    Check dated 2024-05-22T21:23:52.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:49:25.000Z thumbnail image

Stay in the know with updates to Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF

Enter your email address, and we'll notify you when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.